These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27550420)

  • 1.
    Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-FBPA as a tumor specific tracer of L-type amino acid transporter 1 (LAT1): PET evaluation in tumor and inflammation compared to (18)F-FDG and (11)C-methionine.
    Watabe T; Hatazawa J
    Hell J Nucl Med; 2015; 18 Suppl 1():149. PubMed ID: 26665232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
    Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
    Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of D-isomer of
    Hirai N; Watabe T; Nagamori S; Wiriyasermkul P; Tanaka Y; Romanov V; Naka S; Kanai Y; Liu Y; Tani N; Sakai T; Tatsumi M; Shimosegawa E; Kanai Y; Hatazawa J
    Asia Ocean J Nucl Med Biol; 2020; 8(2):102-108. PubMed ID: 32714997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
    J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive estimation of
    Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
    Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
    Yoshimoto M; Kurihara H; Honda N; Kawai K; Ohe K; Fujii H; Itami J; Arai Y
    Nucl Med Biol; 2013 Jul; 40(5):625-9. PubMed ID: 23557719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.
    Yang FY; Chang WY; Li JJ; Wang HE; Chen JC; Chang CW
    J Nucl Med; 2014 Apr; 55(4):616-21. PubMed ID: 24525207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-human assessment of the novel LAT1 targeting PET probe
    Nozaki S; Nakatani Y; Mawatari A; Hume WE; Wada Y; Ishii A; Tanaka M; Tsuyuguchi N; Doi H; Watanabe Y
    Biochem Biophys Res Commun; 2022 Mar; 596():83-87. PubMed ID: 35121373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical calculation method to estimate the absolute boron concentration in tissues using
    Watabe T; Hanaoka K; Naka S; Kanai Y; Ikeda H; Aoki M; Shimosegawa E; Kirihata M; Hatazawa J
    Ann Nucl Med; 2017 Jul; 31(6):481-485. PubMed ID: 28439784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between L-amino acid transporter 1 expression and 4-borono-2-
    Kashihara T; Mori T; Nakaichi T; Nakamura S; Ito K; Kurihara H; Kusumoto M; Itami J; Yoshimoto S; Igaki H
    Cancer Med; 2023 Nov; 12(21):20564-20572. PubMed ID: 37881128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the uptake of
    Watanabe Y; Kurihara H; Itami J; Sasaki R; Arai Y; Sugimura K
    Radiat Oncol; 2017 Jan; 12(1):17. PubMed ID: 28088230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
    Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
    Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS
    Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [
    Beshr R; Isohashi K; Watabe T; Naka S; Horitsugi G; Romanov V; Kato H; Miyatake SI; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2018 Dec; 32(10):702-708. PubMed ID: 30194665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.